MedWatch

Novo Nordisk CEO: Strategy remains constant after Krogsgaard's departure

Novo Nordisk maintains its strategy even though EVP, R&D Head and CSO Mads Krogsgaard Thomsen leaves the firm at the end of the month, according to CEO Lars Fruergaard Jørgensen.

Photo: Stine Bidstrup/ERH

After 20 years in the driver's seat, Mads Krogsgaard Thomsen passes the baton of his Novo Nordisk research and development responsibility areas to two of his lieutenants. The transition will be smooth, since the unit will keep going along the same strategic lines, says Novo Nordisk CEO and President Lars Fruergaard Jørgensen on Wednesday at an investor teleconference in connection with the release of the company's annual report for 2020.

60-year-old Krogsgaard Thomsen is to be succeeded by Marcus Schindler, who will be made chief scientific officer and executive vice president for research and early development, and Martin Holst Lange, who is promoted to executive vice president for development. Each of them has leadership experience in their respective fields.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs